Modernizing Medicine and Miraca Life Sciences Partner to Create Enhanced EMR and Pathology Lab Integration Enhanced Communication Between Dermatologists and Pathologists BOCA RATON, FL -- (Marketwired) -- 09/25/13 -- Modernizing Medicine(R), the creator of the Electronic Medical Assistant(R) (EMA(TM)), a cloud-based, specialty-specific electronic medical record (EMR) system, and Miraca Life Sciences (MLS), a specialist in the development and commercialization of subspecialty expert anatomic pathology services, announced today that they are partnering to develop an enhanced diagnostic data bridge. Pathologists normally analyze tissue samples with limited clinical background on patients, which can delay accurate diagnoses. EMA dermatologists and MLS pathologists will be able to share additional diagnostic information, which can help the pathologist create a more timely, informed and accurate analysis. "This is truly the future of healthcare technology," said Dr. Michael Sherling, Chief Medical Officer and co-founder of Modernizing Medicine. "Structured data stored in the cloud with Modernizing Medicine's EMA EMR is the key to letting us share information with MLS. Working together, we intend to build an enhanced system to improve communications between dermatologists and pathologists which should ultimately help patients -- improved patient care through technology is what we're all about." Modernizing Medicine's user-friendly EMA adapts to each healthcare provider's unique style of practice and integrates seamlessly into the practice's workflow, saving physicians and their staff time and increasing efficiencies. EMA's cloud-based approach to collecting and storing patient information enables physicians to utilize the EMA Network(TM) to create, visualize and consume treatment data to better care for their patients. "Partnering with Modernizing Medicine is a natural fit, since we share the same goals of using technology to accelerate positive change in healthcare," said Richard Lash, MD, Chief Medical Officer of Miraca Life Sciences. "Miraca's existing structured data based on our consensus approach to diagnostic terminology and criteria will complement the rich clinical information provided by Modernizing Medicine, helping ensure the most definitive diagnoses for individual patients while creating a powerful database to help clinicians and pathologists improve patient outcomes." Available as a native iPad application or from any web-enabled Mac or PC, Modernizing Medicine's EMA is developed by physicians for the dermatology, ophthalmology, optometry, orthopedics and plastic and cosmetic surgery markets. This year, Software Advice named EMA the #1 tablet EHR and the company was listed on Forbes' annual ranking of America's Most Promising Companies. About Modernizing Medicine Modernizing Medicine(R) is transforming how healthcare information is created, consumed and utilized in order to increase efficiency and improve outcomes. Its product, Electronic Medical Assistant(R) (EMA(TM)), is a cloud-based, specialty-specific electronic medical record (EMR) system with a massive library of built-in medical content, designed to save physicians time. Available as a native iPad application or from any web-enabled Mac or PC, EMA adapts to each provider's unique style of practice and is designed to interface with hundreds of different practice management systems. Today, Modernizing Medicine provides specialty-specific offerings for the dermatology, ophthalmology, optometry, orthopedics and plastic and cosmetic surgery markets, and to more than 1,000 physician practices across the country. In 2013 Modernizing Medicine was listed at No. 47 on Forbes' annual ranking of America's Most Promising Companies. About Miraca Life Sciences Serving more than 3,500 patients each day, Miraca Life Sciences is a leader in providing an academic-caliber pathology laboratory with diagnostic services in the fields of dermatology, gastroenterology, hematology and urology. Building upon our experience with health IT, we also offer accessible technology solutions to assist healthcare professionals as they work towards accordance with Meaningful Use initiatives. Miraca Life Sciences, a wholly owned subsidiary of Japan-based Miraca Holdings Inc., employs a talented team of leading pathologists, histologists, lab technicians, technology consultants, and other medical professionals -- all driven to help provide the highest and most up-to-date levels of diagnostic quality, enhanced workflow and practice solutions possible. It's part of our commitment: not only to scientific excellence, but to patients and practices. For more information, contact: Tara Auclair Ryan 561-880-2998 x321 firstname.lastname@example.org Lauren Moreno 415-593-1400 email@example.com
Modernizing Medicine and Miraca Life Sciences Partner to Create Enhanced EMR and Pathology Lab Integration
Press spacebar to pause and continue. Press esc to stop.